Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • aosjdhdjduryffjfjfj aosjdhdjduryffjfjfj Sep 30, 2013 4:48 PM Flag

    Remember Dendreon ? I see a siimilar fate for ACAD.

    Acadia has no earnings OR an FDA approval...Similarly, Dendreon rose from 2 to 45 4 years ago, and now, well, Dendreon is 2 bucks a share.
    The same will happen to ACADIA..No earnings will force traders to sell....back to 2 a share. sorry.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is the same poster that had these amazing calls....

      If you`re still holding ACAD , you are nuts
      by aosjdhdjduryffjfjfj • May 28, 2013 10:11 PM Flag
      this is a lottery ticket....any bad news, and ACAD drops to 2 bucks a share. Good news wont move this stock.
      Acadia is done moving up, it can only go down from 14.
      WHO'S NUTS? SORRY....YOU COULD HAVE DOUBLED YOUR MONEY

      take profits in ACAD now !
      by aosjdhdjduryffjfjfj • Jun 11, 2013 6:55 AM Flag
      greed will cost one dearly. From 1 dollar to 20 in 1 year. ACAD upside is 2 dollars, downside is 18 dollars down to 3. ACAD has no revenue and is being used by traders as a lottery ticket.
      I AM NEVER WRONG.
      ACAD IS ONLY UP 49% SINCE JUNE 11th

      by aosjdhdjduryffjfjfj • Aug 19, 2011 4:04 AM Flag
      however, the dow will fall 350 more points today and fall 45% this year..
      the nasdaq may fall as much as 60% this or next year.
      THE DOW ROSE 1400 POINTS IN THOSE NEXT 4 MONTHS

      by aosjdhdjduryffjfjfj • Aug 18, 2011 5:39 PM
      my new price target for HPQ is 57 !!!!!
      HPQ HIT A HIGH OF 30 AND IS NOW TRADING AT $21.31

      I predict the Dow will fall 4000 more points by December...
      new target for the Dow is 6300 by Dec
      The Nasdaq will fall 1300 more points.. and the s@p will fall 655 points...all by Dec. 28, 2011....
      Then we trade sideways for 12-15 years before things get better.
      LOL!!!

      AVON earnings will soar on august 1 when they report
      by aosjdhdjduryffjfjfj • Jul 19, 2013 7:40 AM Flag
      I say Avon is a great company with a strong buy now before earnings.
      Avon is worth 44 a share in a buyout. I am long avon !!!!!!!!!!!!!!
      GREAT CALL...HE ACTUALLY MADE THIS STOCK PICK ON THE HIGHEST CLOSE DAY OF AVP...IT WENT DOWN 15% FROM THERE.

      my NIKE price target 12 months from now is $155
      by aosjdhdjduryffjfjfj • Aug 26, 2011 9:31 PM Flag
      I love nike-155 target
      12 MONTHS LATER NKE WAS TRADING AT 47

      NO SOUP FOR YOU!!! I hope you have a real day job because this stock this is just not for you.

      Sentiment: Hold

    • yep this guy is 100% correct!! No earnings, back to $2.00....in fact you should write this in Seeking Alpha----because that is where all the big money players look for this VERY astute analysis...dont waste your time on this message board---if fact, I would call Baker Bros today and give them a heads up...they definitely need to hear this message...I am thankful----no... extremely grateful, u have taken the time to give us all this thoughtful and well reasoned analysis....toidi em wolb ---look in mirror for the hidden message...lol

    • Funniest post ever.

      Sentiment: Strong Buy

    • do we have all morons on the board today again,just b/c you didnt get in where you could afford it.

      Sentiment: Strong Buy

    • cut your losses....buyers are drooling over shares that shorts sell.....

    • There are a lot of other pharma that have no earnings and no FDA approval but their stock prices are higher than
      ACAD. See CLVS, CLDX and SRPT to mention a few. The prices of this stacks keep on going up as they
      close in to the finalization of phase III.

    • LOL, why so many shorts did not do any dd on ACAD's pima?

      ACAD's pima has NO COMPETITOR. Pima is going to DOMINATE the PDP & ADP market. We'll see.

      Sentiment: Strong Buy

    • Firstly, DNDN released provenge and flew up. People in early make money. Don't be mad that you did not get in as early as you'd have liked. Secondly, provenge (DNDN's drug) was priced at around $93,000 for a treatment that would not extend the patients life by much (was it 3 months?). Considering the fact that that was not too different from other forms of cancer treatment, DNDN faced a hefty challenge. Their in ability to find a suitable backer eventually did them in.

      ACAD has a drug that shows significant improvement compared to other molecules for the same indication. There will be backers. Pharma stocks are priced at multiples of potential earnings. I think ACAD looks like REGN. Another warhorse that keeps flying.

      Sentiment: Strong Buy

    • I say more like $200-$500 in 36 months. You are still on time to catch this train.

      Sentiment: Strong Buy

 
ACAD
18.23-0.25(-1.35%)Feb 10 3:59 PMEST